false
Hamburger Menu
Catalog
Targeting NTRK in NSCLC
Targeting NTRK in NSCLC
Podcast | English | 2022 | 32 Min
Create Account
Credit
No Credit Offered
Summary
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Dr. Robert C. Doebele, Co-Founder and Chief Scientific Officer, Rain Therapeutics about NTKR gene fusions, including recent and emerging breakthrough therapies.
Faculty
Dr. Narjust Duma
Dr. Robert C. Doebele
×
Targeting NTRK in NSCLC Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Create Account
Forgot Password
×
Please select your language
1
English